Serveur d'exploration H2N2 - Curation (Istex)

Index « AbsEn.i » - entrée « treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
treating < treatment < treatments  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 90.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2013) Richard Pažout ; Jaroslav Maixner ; Michaela Hrdá ; Tereza Loužilová ; Petr Ka ErA bromine analogue of picoplatin: a new substance from the group of platinum‐based chemotherapeutics
000055 (1980) J. Drescher [Allemagne] ; U. Desselberger [Allemagne]Comparison of the antineuraminidase antibody response to vaccination with intact virus and subunit preparations obtained by different techniques of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2)
000067 (1980) Amantadine: Does It Have a Role in the Prevention and Treatment of Influenza?
000106 (1995) Alexander I. Klimov [États-Unis] ; Nancy J. Cox [États-Unis]PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines
000122 (1980) Ann H. Erickson [États-Unis] ; Edwin D. Kilbourne [États-Unis]Mutation in the hemagglutinin of A/N-WS/33 influenza virus recombinants influencing sensitivity to trypsin and antigenic reactivity
000214 (2004) Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
000215 (1999) Hiroshi Kido [Japon] ; Yoshihito Beppu [Japon] ; Yasuhiro Imamura [Japon] ; Ye Chen [Japon] ; Meiko Murakami [Japon] ; Kumiko Oba [Japon] ; Takae Towatari [Japon]The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
000233 (2001) B. Schweiger [États-Unis]Nationale und globale Influenzasurveillance als Basis der jährlichen Impfstoffempfehlung
000249 (1999) J. Yoshimoto [Japon] ; M. Kakui [Japon] ; H. Iwasaki [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hattori [Japon]Identification of a novel HA conformational change inhibitor of human influenza virus
000257 (1984) R. G. Webster [États-Unis] ; L. E. Brown [États-Unis] ; W. G. Laver [États-Unis]Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies
000259 (1996) Pedro A. Piedra [États-Unis]Rimantadine: Chemoprophylaxis and treatment
000307 (1980) E. Liehl [Autriche] ; D. Armerding [Autriche] ; J. Böckmann [Autriche]Effektorfunktionen und protektive Wirkung von Standardimmunglobulin und Immunglobulin nach modifizierter milder Säurebehandlung
000328 (1978) J. Drescher [Allemagne]Description of a technique for the analysis of antineuraminidase antibodies oriented to H2N2 and H3N2 influenza virus strains
000452 (1976) Nancy J. Cox [États-Unis] ; Alan P. Kendal [États-Unis]Presence of a segmented single-stranded RNA genome in influenza C virus
000502 (1980) J. Drescher [Allemagne] ; U. Desselberger [Allemagne]Antineuraminidase antibody response to vaccination of chickens with intact virus and different subunit preparations of the influenza virus strains A/Sing/1/57 (H2N2), A/Hong Kong/1/68 (H3N2) and A/Port Chalmers/1/73 (H3N2)
000509 (2012) R. K. Saxena [Inde] ; P. Tripathi [Inde] ; G. Rawat [Inde]Pandemism of swine flu and its prospective drug therapy
000530 (1990) L. A. White [États-Unis] ; C. Y. Freeman [États-Unis] ; H. E. Hall [États-Unis] ; B. D. Forrester [États-Unis]Inactivation and stability of viral diagnostic reagents treated by gamma radiation
000552 (2005) Susan Mayor [Royaume-Uni]Aggressive treatment of low grade prostate cancer is unnecessary
000604 (1975) Dagmar Cursiefen ; Hermann BechtIn vitro cultivation of cells from the chorioallantoic membrane of chick embryos
000618 (2007) William B. Ershler [États-Unis] ; Stefan Gravenstein [États-Unis] ; Zeba S. Geloo [États-Unis]Thymosin Alpha 1 as an Adjunct to Influenza Vaccination in the Elderly
000630 (2000) Y. A. Smirnov ; A. S. Lipatov ; A. K. Gitelman ; E. C. J. Claas ; A. D. M. E. OsterhausPrevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "treatment" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    treatment
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021